A few studies suggest that ABCG2 in MM cells may contribute to intrinsic drug resistance, which is increased when the cells are exposed to ABCG2 substrates such as doxorubicin or topotecan (200, 201). This evidence concerns the gene ABCG2 and Miyoshi myopathy.